nitracrine has been researched along with Leukemia P388 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borissevich, IE; Degterev, IA; Rocha-e-Silva, TA; Rossa, MM; Selistre-de-Araujo, HS; Tedesco, AC; Terruggi, CH | 1 |
| Borissevitch, IE; Daghastanli, NA; Degterev, IA; Rossa, MM; Selistre-De-Araujo, HS; Tedesco, AC | 1 |
2 other study(ies) available for nitracrine and Leukemia P388
| Article | Year |
|---|---|
Comparison of the cytotoxicity of two nitroheterocyclic drugs (NHCD) towards transformed and non-transformed cells.
Topics: Animals; Cell Hypoxia; Cell Line; Cell Line, Transformed; Humans; K562 Cells; Leukemia P388; Mice; NIH 3T3 Cells; Nitracrine; Quinolines; Tumor Cells, Cultured | 2003 |
Cytotoxicity of nitroheterocyclic compounds, quinifuryl and nitracrine, towards leukaemic and normal cells on the dark and under illumination with visible light.
Topics: Animals; Antineoplastic Agents; Cell Survival; Darkness; Drug Evaluation, Preclinical; Humans; K562 Cells; Leukemia P388; Light; Mice; NIH 3T3 Cells; Nitracrine; Quinolines | 2004 |